{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:26:21Z","timestamp":1786983981468,"version":"build-2736575974"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.abb.2020.108670","type":"journal-article","created":{"date-parts":[[2020,11,10]],"date-time":"2020-11-10T11:17:02Z","timestamp":1605007022000},"page":"108670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Nuclear factor erythroid 2-related factor 2 (Nrf2) as a potential therapeutic target for vitiligo"],"prefix":"10.1016","volume":"696","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6860-4263","authenticated-orcid":false,"given":"Xiran","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianmin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.abb.2020.108670_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/imr.12369","article-title":"Cellular stress and innate inflammation in organ-specific autoimmunity: lessons learned from vitiligo","volume":"269","author":"Harris","year":"2016","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.abb.2020.108670_bib2","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/1523-1747.ep12476645","article-title":"Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation","volume":"100","author":"Le Poole","year":"1993","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.abb.2020.108670_bib3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/exd.13677","article-title":"The convergence theory for vitiligo: a reappraisal","volume":"28","author":"Kundu","year":"2019","journal-title":"Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.abb.2020.108670_bib4","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/exd.13858","article-title":"Molecular and cellular basis of depigmentation in vitiligo patients","volume":"28","author":"Delmas","year":"2019","journal-title":"Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.abb.2020.108670_bib5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/1523-1747.ep12335801","article-title":"Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo","volume":"109","author":"Maresca","year":"1997","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.abb.2020.108670_bib6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1365-2133.2001.03952.x","article-title":"Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo","volume":"144","author":"Jimbow","year":"2001","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.abb.2020.108670_bib7","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.0022-202X.2005.23653.x","article-title":"4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo","volume":"124","author":"Kroll","year":"2005","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.abb.2020.108670_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2015.09.003","article-title":"Vitiligo: how do oxidative stress-induced autoantigens trigger autoimmunity?","volume":"81","author":"Xie","year":"2016","journal-title":"J. Dermatol. Sci."},{"issue":"20","key":"10.1016\/j.abb.2020.108670_bib9","doi-asserted-by":"crossref","first-page":"13291","DOI":"10.1074\/jbc.R900010200","article-title":"The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress","volume":"284","author":"Nguyen","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.abb.2020.108670_bib10","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1038\/jid.2014.241","article-title":"Oxidative stress and vitiligo: the Nrf2-ARE signaling connection","volume":"134","author":"Qiu","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"8","key":"10.1016\/j.abb.2020.108670_bib11","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1128\/MCB.15.8.4184","article-title":"Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins","volume":"15","author":"Itoh","year":"1995","journal-title":"Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.abb.2020.108670_bib12","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1002\/jcp.29219","article-title":"Nrf2-ARE signaling in cellular protection: mechanism of action and the regulatory mechanisms","volume":"235","author":"Shaw","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"17","key":"10.1016\/j.abb.2020.108670_bib13","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.1073\/pnas.0305902101","article-title":"Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway","volume":"101","author":"Motohashi","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.abb.2020.108670_bib14","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1128\/MCB.26.8.2887-2900.2006","article-title":"Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model","volume":"26","author":"Tong","year":"2006","journal-title":"Mol. Cell Biol."},{"issue":"34","key":"10.1016\/j.abb.2020.108670_bib15","doi-asserted-by":"crossref","first-page":"24756","DOI":"10.1074\/jbc.M601119200","article-title":"Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a \"tethering\" mechanism: a two-site interaction model for the Nrf2-Keap1 complex","volume":"281","author":"McMahon","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"Pt B","key":"10.1016\/j.abb.2020.108670_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.freeradbiomed.2015.05.034","article-title":"Structural basis of Keap1 interactions with Nrf2","volume":"88","author":"Canning","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"39","key":"10.1016\/j.abb.2020.108670_bib17","doi-asserted-by":"crossref","first-page":"36544","DOI":"10.1074\/jbc.M206530200","article-title":"The Keap1 BTB\/POZ dimerization function is required to sequester Nrf2 in cytoplasm","volume":"277","author":"Zipper","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"52","key":"10.1016\/j.abb.2020.108670_bib18","doi-asserted-by":"crossref","first-page":"54750","DOI":"10.1074\/jbc.M410073200","article-title":"Crystal structure of the Kelch domain of human Keap1","volume":"279","author":"Li","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.abb.2020.108670_bib19","doi-asserted-by":"crossref","first-page":"21592","DOI":"10.1074\/jbc.M300931200","article-title":"Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression","volume":"278","author":"McMahon","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.abb.2020.108670_bib20","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1128\/MCB.24.16.7130-7139.2004","article-title":"Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2","volume":"24","author":"Kobayashi","year":"2004","journal-title":"Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.abb.2020.108670_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2443.2010.01473.x","article-title":"Molecular mechanisms of the Keap1\u2013Nrf2 pathway in stress response and cancer evolution","volume":"16","author":"Taguchi","year":"2011","journal-title":"Gene Cell."},{"issue":"3","key":"10.1016\/j.abb.2020.108670_bib22","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","article-title":"The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis","volume":"98","author":"Yamamoto","year":"2018","journal-title":"Physiol. Rev."},{"issue":"14","key":"10.1016\/j.abb.2020.108670_bib23","first-page":"969","article-title":"[Association of single nucleotide polymorphisms of Nrf2 promoter region with susceptibility to vitiligo]","volume":"88","author":"Zhou","year":"2008","journal-title":"Zhonghua Yixue Zazhi"},{"issue":"12","key":"10.1016\/j.abb.2020.108670_bib24","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1600-0625.2008.00752.x","article-title":"The susceptibility to vitiligo is associated with NF-E2-related factor2 (Nrf2) gene polymorphisms: a study on Chinese Han population","volume":"17","author":"Guan","year":"2008","journal-title":"Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.abb.2020.108670_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbrc.2007.05.218","article-title":"Hydrogen peroxide-mediated oxidative stress disrupts calcium binding on calmodulin: more evidence for oxidative stress in vitiligo","volume":"360","author":"Schallreuter","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"9","key":"10.1016\/j.abb.2020.108670_bib26","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1600-0625.2008.00697.x","article-title":"Presence of epidermal allantoin further supports oxidative stress in vitiligo","volume":"17","author":"Shalbaf","year":"2008","journal-title":"Exp. Dermatol."},{"issue":"7","key":"10.1016\/j.abb.2020.108670_bib27","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/jid.2011.56","article-title":"Heme oxygenase-1 protects human melanocytes from H2O2-induced oxidative stress via the Nrf2-ARE pathway","volume":"131","author":"Jian","year":"2011","journal-title":"J. Invest. Dermatol."},{"issue":"8","key":"10.1016\/j.abb.2020.108670_bib28","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1038\/jid.2014.152","article-title":"Impaired activation of the Nrf2-ARE signaling pathway undermines H2O2-induced oxidative stress response: a possible mechanism for melanocyte degeneration in vitiligo","volume":"134","author":"Jian","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"34","key":"10.1016\/j.abb.2020.108670_bib29","first-page":"2403","article-title":"[Abnormal nuclear translocation of nuclear factor-E2 related factor 2 in the lesion of vitiligo]","volume":"88","author":"Guan","year":"2008","journal-title":"Zhonghua Yixue Zazhi"},{"issue":"38","key":"10.1016\/j.abb.2020.108670_bib30","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.1038\/sj.onc.1205743","article-title":"DNA damage, death receptor activation and reactive oxygen species contribute to ultraviolet radiation-induced apoptosis in an essential and independent way","volume":"21","author":"Kulms","year":"2002","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.abb.2020.108670_bib31","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/s41598-017-01305-2","article-title":"Melatonin and its metabolites protect human melanocytes against UVB-induced damage: involvement of NRF2-mediated pathways","volume":"7","author":"Janjetovic","year":"2017","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.abb.2020.108670_bib32","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/exd.13277","article-title":"Melanocyte-protective effect of afzelin is mediated by the Nrf2-ARE signalling pathway via GSK-3\u03b2 inactivation","volume":"26","author":"Jung","year":"2017","journal-title":"Exp. Dermatol."},{"issue":"2","key":"10.1016\/j.abb.2020.108670_bib33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s12192-020-01071-7","article-title":"Apigenin protects human melanocytes against oxidative damage by activation of the Nrf2 pathway","volume":"25","author":"Zhang","year":"2020","journal-title":"Cell Stress Chaperones"},{"issue":"7","key":"10.1016\/j.abb.2020.108670_bib34","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/jcmm.12812","article-title":"Aspirin induces Nrf2-mediated transcriptional activation of haem oxygenase-1 in protection of human melanocytes from H2 O2 -induced oxidative stress","volume":"20","author":"Jian","year":"2016","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.abb.2020.108670_bib35","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.freeradbiomed.2018.10.421","article-title":"Baicalein protects human vitiligo melanocytes from oxidative stress through activation of NF-E2-related factor2 (Nrf2) signaling pathway","volume":"129","author":"Ma","year":"2018","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.abb.2020.108670_bib36","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jdermsci.2019.03.007","article-title":"Berberine protects immortalized line of human melanocytes from H2O2-induced oxidative stress via activation of Nrf2 and Mitf signaling pathway","volume":"94","author":"Jiang","year":"2019","journal-title":"J. Dermatol. Sci."},{"issue":"7","key":"10.1016\/j.abb.2020.108670_bib37","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1111\/jcmm.15038","article-title":"Cistanche deserticola polysaccharide induces melanogenesis in melanocytes and reduces oxidative stress via activating NRF2\/HO-1 pathway","volume":"24","author":"Hu","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"20","key":"10.1016\/j.abb.2020.108670_bib38","first-page":"S0022","article-title":"Molecular hydrogen protects human melanocytes from oxidative stress by activating Nrf2 signaling","author":"Fang","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.abb.2020.108670_bib39","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3389\/fphar.2020.00536","article-title":"Paeoniflorin resists H2O2-induced oxidative stress in melanocytes by JNK\/Nrf2\/HO-1 pathway","volume":"11","author":"Yuan","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.abb.2020.108670_bib40","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.3390\/ijms21103537","article-title":"6-Shogaol protects human melanocytes against oxidative stress through activation of the nrf2-antioxidant response element signaling pathway","volume":"21","author":"Yang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.abb.2020.108670_bib41","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jid.2017.01.020","article-title":"Simvastatin protects human melanocytes from H2O2-induced oxidative stress by activating Nrf2","volume":"137","author":"Chang","year":"2017","journal-title":"J. Invest. Dermatol."},{"issue":"7","key":"10.1016\/j.abb.2020.108670_bib42","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1038\/jid.2011.56","article-title":"Heme oxygenase-1 protects human melanocytes from H2O2-induced oxidative stress via the Nrf2-ARE pathway","volume":"131","author":"Jian","year":"2011","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.abb.2020.108670_bib43","first-page":"799","article-title":"Decreased proinflammatory cytokine production by peripheral blood mononuclear cells from vitiligo patients following aspirin treatment","volume":"26","author":"Zailaie","year":"2005","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.abb.2020.108670_bib44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-511X-3-7","article-title":"Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo","volume":"3","author":"No\u00ebl","year":"2004","journal-title":"Lipids Health Dis."},{"issue":"25","key":"10.1016\/j.abb.2020.108670_bib45","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.2174\/092986711803414368","article-title":"Antioxidant therapy: current status and future prospects","volume":"18","author":"Firuzi","year":"2011","journal-title":"Curr. Med. Chem."},{"issue":"12","key":"10.1016\/j.abb.2020.108670_bib46","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1111\/bph.13544","article-title":"The oxidative stress theory of disease: levels of evidence and epistemological aspects","volume":"174","author":"Ghezzi","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.abb.2020.108670_bib47","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3389\/fphys.2018.00477","article-title":"Role of ROS and nutritional antioxidants in human diseases","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Physiol."},{"issue":"11","key":"10.1016\/j.abb.2020.108670_bib48","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.bmcl.2015.04.019","article-title":"Non-electrophilic modulators of the canonical Keap1\/Nrf2 pathway","volume":"25","author":"Richardson","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.abb.2020.108670_bib49","doi-asserted-by":"crossref","first-page":"9372182","DOI":"10.1155\/2019\/9372182","article-title":"Activators and inhibitors of NRF2: a review of their potential for clinical development","volume":"2019","author":"Robledinos-Ant\u00f3n","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.abb.2020.108670_bib50","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.12688\/f1000research.12111.1","article-title":"Recent advances in understanding NRF2 as a druggable target: development of pro-electrophilic and non-covalent NRF2 activators to overcome systemic side effects of electrophilic drugs like dimethyl fumarate","volume":"6","author":"Satoh","year":"2017","journal-title":"F1000Res"},{"key":"10.1016\/j.abb.2020.108670_bib51","doi-asserted-by":"crossref","first-page":"3172692","DOI":"10.1155\/2017\/3172692","article-title":"NRF2 plays a critical role in both self and EGCG protection against diabetic testicular damage","volume":"2017","author":"Pan","year":"2017","journal-title":"Oxid Med Cell Longev"},{"issue":"7","key":"10.1016\/j.abb.2020.108670_bib52","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/exd.13350","article-title":"The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone","volume":"26","author":"Arowojolu","year":"2017","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.abb.2020.108670_bib53","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.nbd.2015.07.001","article-title":"Dimethyl fumarate confers neuroprotection by casein kinase 2 phosphorylation of Nrf2 in murine intracerebral hemorrhage","volume":"82","author":"Iniaghe","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.abb.2020.108670_bib54","first-page":"116","article-title":"Curcumin activates the Nrf2 pathway and induces cellular protection against oxidative injury","volume":"20","author":"Ashrafizadeh","year":"2020","journal-title":"Curr. Mol. Med."},{"issue":"5","key":"10.1016\/j.abb.2020.108670_bib55","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1089\/pho.2009.2637","article-title":"Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study","volume":"28","author":"Asawanonda","year":"2010","journal-title":"Photomed Laser Surg"},{"issue":"4","key":"10.1016\/j.abb.2020.108670_bib56","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.fct.2007.10.006","article-title":"Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG","volume":"46","author":"Na","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.abb.2020.108670_bib57","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.fitote.2014.08.007","article-title":"The therapeutic effects of EGCG on vitiligo","volume":"99","author":"Zhu","year":"2014","journal-title":"Fitoterapia"},{"issue":"2 Suppl 2","key":"10.1016\/j.abb.2020.108670_bib58","first-page":"AB170","article-title":"Phase II management of vitiligo with 5% polyphenone (-EGCg) in a hydrophilic cream. A placebo-controlled, double-blind study","volume":"56","author":"Syed","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"issue":"8","key":"10.1016\/j.abb.2020.108670_bib59","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s40262-016-0501-5","article-title":"Pharmacokinetics and pharmacodynamics of afamelanotide and its clinical use in treating dermatologic disorders","volume":"56","author":"Minder","year":"2017","journal-title":"Clin. Pharmacokinet."},{"issue":"7","key":"10.1016\/j.abb.2020.108670_bib60","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1210\/en.2008-1315","article-title":"Alpha-melanocyte-stimulating hormone counteracts the suppressive effect of UVB on Nrf2 and Nrf-dependent gene expression in human skin","volume":"150","author":"Kokot","year":"2009","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.abb.2020.108670_bib61","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/2013.jamadermatol.386","article-title":"The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo","volume":"149","author":"Grimes","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.abb.2020.108670_bib62","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jamadermatol.2014.1875","article-title":"Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial","volume":"151","author":"Lim","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"8","key":"10.1016\/j.abb.2020.108670_bib63","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1111\/jcmm.14393","article-title":"Ginkgo biloba extract protects human melanocytes from H2 O2 -induced oxidative stress by activating Nrf2","volume":"23","author":"Zhang","year":"2019","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.abb.2020.108670_bib64","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2230.2003.01207.x","article-title":"Effectiveness of oral Ginkgo biloba in treating limited, slowly spreading vitiligo","volume":"28","author":"Parsad","year":"2003","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.abb.2020.108670_bib65","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1472-6882-11-21","article-title":"Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial","volume":"11","author":"Szczurko","year":"2011","journal-title":"BMC Compl. Alternative Med."},{"issue":"1","key":"10.1016\/j.abb.2020.108670_bib66","first-page":"253","article-title":"Glycyrrhizin protects human melanocytes from H2O2-induced oxidative damage via the Nrf2-dependent induction of HO-1","volume":"44","author":"Mou","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.abb.2020.108670_bib67","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.lfs.2017.11.005","article-title":"Glycyrrhizin ameliorates high fat diet-induced obesity in rats by activating NrF2 pathway","volume":"193","author":"Abo El-Magd","year":"2018","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.abb.2020.108670_bib68","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.intimp.2015.03.014","article-title":"Glycyrrhizin reduces HMGB1 secretion in lipopolysaccharide-activated RAW 264.7 cells and endotoxemic mice by p38\/Nrf2-dependent induction of HO-1","volume":"26","author":"Kim","year":"2015","journal-title":"Int. Immunopharm."},{"issue":"8","key":"10.1016\/j.abb.2020.108670_bib69","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20165354","article-title":"Combination therapy of orally administered glycyrrhizin and UVB improved active-stage generalized vitiligo","volume":"49","author":"Mou","year":"2016","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"2","key":"10.1016\/j.abb.2020.108670_bib70","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: far beyond an antibiotic","volume":"169","author":"Garrido-Mesa","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.abb.2020.108670_bib71","doi-asserted-by":"crossref","first-page":"34228","DOI":"10.1038\/srep34228","article-title":"Stabilization of endogenous Nrf2 by minocycline protects against Nlrp3-inflammasome induced diabetic nephropathy","volume":"6","author":"Shahzad","year":"2016","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.abb.2020.108670_bib72","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1523\/JNEUROSCI.5686-11.2012","article-title":"Minocycline-preconditioned neural stem cells enhance neuroprotection after ischemic stroke in rats","volume":"32","author":"Sakata","year":"2012","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.abb.2020.108670_bib73","first-page":"9","article-title":"Minocycline protects melanocytes against H2O2-induced cell death via JNK and p38 MAPK pathways","volume":"22","author":"Song","year":"2008","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.abb.2020.108670_bib74","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1530\/JME-17-0260","article-title":"SP600125 suppresses Keap1 expression and results in NRF2-mediated prevention of diabetic nephropathy","volume":"60","author":"Zhang","year":"2018","journal-title":"J. Mol. Endocrinol."},{"issue":"3","key":"10.1016\/j.abb.2020.108670_bib75","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1529-8019.2010.01328.x","article-title":"Oral minocycline in the treatment of vitiligo--a preliminary study","volume":"23","author":"Parsad","year":"2010","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.abb.2020.108670_bib76","doi-asserted-by":"crossref","first-page":"240856","DOI":"10.1155\/2014\/240856","article-title":"Narrow-Band ultraviolet B versus oral minocycline in treatment of unstable vitiligo: a prospective comparative trial","volume":"2014","author":"Siadat","year":"2014","journal-title":"Dermatol Res Pract"},{"issue":"1","key":"10.1016\/j.abb.2020.108670_bib77","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/0378-6323.148562","article-title":"Randomized controlled study to evaluate the effectiveness of dexamethasone oral minipulse therapy versus oral minocycline in patients with active vitiligo vulgaris","volume":"80","author":"Singh","year":"2014","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"issue":"9","key":"10.1016\/j.abb.2020.108670_bib78","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jnutbio.2006.11.012","article-title":"Piperine protects cisplatin-induced apoptosis via heme oxygenase-1 induction in auditory cells","volume":"18","author":"Choi","year":"2007","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.abb.2020.108670_bib79","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.intimp.2016.11.001","article-title":"Piperine attenuates lipopolysaccharide (LPS)-induced inflammatory responses in BV2 microglia","volume":"42","author":"Wang-Sheng","year":"2017","journal-title":"Int. Immunopharm."},{"issue":"9","key":"10.1016\/j.abb.2020.108670_bib80","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1002\/ptr.6116","article-title":"The effect of topical piperine combined with narrowband UVB on vitiligo treatment: a clinical trial study","volume":"32","author":"Shafiee","year":"2018","journal-title":"Phytother Res."},{"issue":"8","key":"10.1016\/j.abb.2020.108670_bib81","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.bmc.2004.01.036","article-title":"Effects of piperine analogues on stimulation of melanocyte proliferation and melanocyte differentiation","volume":"12","author":"Venkatasamy","year":"2004","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.abb.2020.108670_bib82","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1365-2133.2008.08464.x","article-title":"In vivo evaluation of piperine and synthetic analogues as potential treatments for vitiligo using a sparsely pigmented mouse model","volume":"158","author":"Faas","year":"2008","journal-title":"Br. J. Dermatol."},{"issue":"7","key":"10.1016\/j.abb.2020.108670_bib83","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3390\/ijms17071026","article-title":"Fernblock (polypodium leucotomos extract): molecular mechanisms and pleiotropic effects in light-related skin conditions, photoaging and skin cancers, a review","volume":"17","author":"Parrado","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.abb.2020.108670_bib84","first-page":"13","article-title":"Polypodium leucotomos as an adjunct treatment of pigmentary disorders","volume":"7","author":"Nestor","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.abb.2020.108670_bib85","first-page":"2908108","article-title":"Fernblock\u00ae upregulates NRF2 antioxidant pathway and protects keratinocytes from PM2.5-induced Xenotoxic stress","author":"Delgado-Wicke","year":"2020","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"10.1016\/j.abb.2020.108670_bib86","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jdermsci.2005.12.006","article-title":"Systemic immunomodulatory effects of Polypodium leucotomos as an adjuvant to PUVA therapy in generalized vitiligo: a pilot study","volume":"41","author":"Reyes","year":"2006","journal-title":"J. Dermatol. Sci."},{"issue":"7","key":"10.1016\/j.abb.2020.108670_bib87","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1468-3083.2006.02132.x","article-title":"Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study","volume":"21","author":"Middelkamp-Hup","year":"2007","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"5","key":"10.1016\/j.abb.2020.108670_bib88","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/biomedicines8050122","article-title":"Flavolignans from silymarin as Nrf2 bioactivators and their therapeutic applications","volume":"8","author":"Vargas-Mendoza","year":"2020","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.abb.2020.108670_bib89","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/09546634.2019.1595506","article-title":"Can we consider silymarin as a treatment option for vitiligo? A double-blind controlled randomized clinical trial of phototherapy plus oral Silybum marianum product versus phototherapy alone","volume":"31","author":"Jowkar","year":"2020","journal-title":"J. Dermatol. Treat."},{"issue":"4","key":"10.1016\/j.abb.2020.108670_bib90","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2174\/138945008783954970","article-title":"Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation","volume":"9","author":"Birlea","year":"2008","journal-title":"Curr. Drug Targets"},{"issue":"6","key":"10.1016\/j.abb.2020.108670_bib91","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/ijms19061618","article-title":"Role of vitamin D beyond the skeletal function: a review of the molecular and clinical studies","volume":"19","author":"Umar","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.abb.2020.108670_bib92","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/s41374-018-0126-4","article-title":"Vitamin D protects human melanocytes against oxidative damage by activation of Wnt\/\u03b2-catenin signaling","volume":"98","author":"Tang","year":"2018","journal-title":"Lab. Invest."},{"issue":"4","key":"10.1016\/j.abb.2020.108670_bib93","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/ajh\/hpt160","article-title":"Vitamin D activates the Nrf2-Keap1 antioxidant pathway and ameliorates nephropathy in diabetic rats","volume":"27","author":"Nakai","year":"2014","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.abb.2020.108670_bib94","doi-asserted-by":"crossref","first-page":"108586","DOI":"10.1016\/j.steroids.2020.108586","article-title":"Active form of vitamin D analogue mitigates neurodegenerative changes in Alzheimer's disease in rats by targeting Keap1\/Nrf2 and MAPK-38p\/ERK signaling pathways","volume":"156","author":"Saad El-Din","year":"2020","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/j.abb.2020.108670_bib95","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1365-2133.2001.04381.x","article-title":"Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo","volume":"145","author":"Ameen","year":"2001","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.abb.2020.108670_bib96","first-page":"11","article-title":"Calcipotriol in the treatment of childhood vitiligo","volume":"24","author":"Gargoom","year":"2004","journal-title":"Int. J. Clin. Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.abb.2020.108670_bib97","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1468-3083.2002.00407.x","article-title":"Treatment of vitiligo by topical calcipotriol","volume":"16","author":"Chiav\u00e9rini","year":"2002","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.abb.2020.108670_bib98","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000017991","article-title":"Combination of PUVAsol and topical calcipotriol in vitiligo","volume":"197","author":"Parsad","year":"1998","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.abb.2020.108670_bib99","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1365-2133.2001.04286.x","article-title":"Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study","volume":"145","author":"Ermis","year":"2001","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.abb.2020.108670_bib100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1468-3083.2003.00795.x","article-title":"Is the combination of calcipotriol and PUVA effective in vitiligo?","volume":"17","author":"Baysal","year":"2003","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"5","key":"10.1016\/j.abb.2020.108670_bib101","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D32FK376FR","article-title":"Calcipotriol and PUVA as treatment for vitiligo","volume":"9","author":"Cherif","year":"2003","journal-title":"Dermatol. Online J."},{"issue":"2","key":"10.1016\/j.abb.2020.108670_bib102","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-0781.2005.00139.x","article-title":"No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalized vitiligo","volume":"21","author":"Ada","year":"2005","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"issue":"5","key":"10.1016\/j.abb.2020.108670_bib103","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1346-8138.2006.00079.x","article-title":"Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo","volume":"33","author":"Arca","year":"2006","journal-title":"J. Dermatol."},{"issue":"5","key":"10.1016\/j.abb.2020.108670_bib104","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1468-3083.2006.01546.x","article-title":"Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo","volume":"20","author":"Goktas","year":"2006","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.abb.2020.108670_bib105","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1365-2230.2005.02037.x","article-title":"Tacalcitol and narrow-band phototherapy in patients with vitiligo","volume":"31","author":"Leone","year":"2006","journal-title":"Clin. Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.abb.2020.108670_bib106","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1600-0781.2006.00250.x","article-title":"Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo","volume":"22","author":"Lu-yan","year":"2006","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"issue":"4","key":"10.1016\/j.abb.2020.108670_bib107","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1468-3083.2006.02016.x","article-title":"Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo","volume":"21","author":"Goldinger","year":"2007","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"2","key":"10.1016\/j.abb.2020.108670_bib108","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2133.2008.08906.x","article-title":"Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo","volume":"160","author":"Rodr\u00edguez-Mart\u00edn","year":"2009","journal-title":"Br. J. Dermatol."},{"issue":"5","key":"10.1016\/j.abb.2020.108670_bib109","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/jdv.12726","article-title":"Comparison of efficacy and safety profile of topical calcipotriol ointment in combination with NB-UVB vs. NB-UVB alone in the treatment of vitiligo: a 24-week prospective right-left comparative clinical trial","volume":"29","author":"Khullar","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"5\u20136","key":"10.1016\/j.abb.2020.108670_bib110","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/phpp.12265","article-title":"Tacalcitol: a useful adjunct to narrow-band ultraviolet-B phototherapy in vitiligo","volume":"32","author":"Sahu","year":"2016","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"issue":"3","key":"10.1016\/j.abb.2020.108670_bib111","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1468-3083.2006.01420.x","article-title":"Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo","volume":"20","author":"Kumaran","year":"2006","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.abb.2020.108670_bib112","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4161\/derm.24808","article-title":"A pilot study assessing the effect of prolonged administration of high daily doses of vitamin D on the clinical course of vitiligo and psoriasis","volume":"5","author":"Finamor","year":"2013","journal-title":"Dermatoendocrinol"},{"key":"10.1016\/j.abb.2020.108670_bib113","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.clnesp.2016.05.006","article-title":"Vitamin D status and the effects of oral vitamin D treatment in children with vitiligo: a prospective study","volume":"15","author":"Karag\u00fczel","year":"2016","journal-title":"Clin Nutr ESPEN"},{"issue":"3\u20134","key":"10.1016\/j.abb.2020.108670_bib114","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1024\/0300-9831\/a000605","article-title":"Evidence of a possible therapeutic role of vitamin D in a cohort of adult Caucasian vitiligo patients","volume":"90","author":"Colucci","year":"2020","journal-title":"Int. J. Vitam. Nutr. Res."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986120306792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986120306792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T13:48:08Z","timestamp":1733233688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986120306792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":114,"alternative-id":["S0003986120306792"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2020.108670","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nuclear factor erythroid 2-related factor 2 (Nrf2) as a potential therapeutic target for vitiligo","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2020.108670","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108670"}}